Cardiovascular Devices Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	155 Pages	Fortune Business Insights Pvt. Ltd.	October, 2024	FOB19224263

Best Price Guarantee
Price	from $4,850
Length	155 Pages
Publisher	Fortune Business Insights Pvt. Ltd.
Published Date	October, 2024
SKU	FOB19224263

Cardiovascular Devices Market

Growth Factors of Cardiovascular Devices Market

The cardiovascular devices market size was valued at USD 61.39 billion in 2023, and the market is now projected to grow from USD 65.63 billion in 2024 to USD 117.68 billion by 2032, exhibiting a CAGR of 7.6% during the forecast period of 2024-2032.

Pandemic negatively impacted the worldwide marketplace via manner of deferring optionally available cardiovascular strategies due to declining health facility visits. While a few strategies are considered pressing, others may be behind schedule. The reduced range of diagnostic strategies has delivered approximately a decline in demand for those gadgets, but the marketplace has given that decrease again to pre-pandemic boom ranges.

The upward push in heart illnesses, which includes coronary heart failure and coronary artery sickness, is riding the increase of the cardiovascular gadgets market. Coronary stents are vital for treating existence-threatening situations. The prevalence of those sicknesses increases the need for advanced heart gadgets international. In the U.S., 4.9% of adults have coronary coronary heart disease, and cardiovascular diseases are the leading reason of dying. Increased device approvals and projects to expand get access to growing regions are anticipated to develop cardiovascular devices market growth.

Advanced heart ailment patients call for advanced diagnostic and therapeutic cardiovascular devices because of growing cognizance and call for secure, reliable gadgets. Technological improvements have caused the emergence of modern merchandise like Medtronic's Arctic Front Cardiac Cryoablation Catheter System and Remo Care Solutions' Al, Remo Cardia, which provide realistic treatment plans and simplicity of usability. As the range of patients choosing cardiovascular gadgets increases, the demand for these devices is predicted to grow.

Comprehensive Analysis of Cardiovascular Devices Market

The global market for diagnostic and monitoring devices is segmented into diagnostic and monitoring devices, therapeutic and surgical devices, and applications. The therapeutic and surgical devices segment is expected to grow due to the increasing demand for advanced cardiac devices for therapeutic purposes. The diagnostic and monitoring devices segment is predicted to record a lower growth rate but still holds a considerable global market share. Applications include coronary artery disease (CAD), cardiac arrhythmia, and heart failure. Hospitals are the leading segment in terms of revenue, as they require trained medical professionals to insert critical devices and reduce adverse reactions during critical medical procedures. Specialty clinics are expected to be a rapidly growing segment with a comparatively significant CAGR.

The North America region lead the cardiovascular devices market share by benefitting a market size of USD 32.07 billion in 2023 due to key manufacturers and growing coronary heart sickness prevalence within the US and Canada, with cardiovascular diseases accounting for USD 18.6 million deaths in 2019.

The market is competitive with businesses like Medtronic, Abbott, Boston Scientific Corporation, and Edwards Lifesciences dominating the marketplace. Other distinguished players include B. Braun Melsungen AG, Medtronic, GE Healthcare, and others.

In November 2023 Cardio Diagnostics Holdings and Vizient introduced their partnership for Al cardiovascular.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 7.6% from 2024-2032

Unit Value (USD billion)

Segmentation

By Device Type

Diagnostic and Monitoring Devices
Electrocardiogram (ECG)
Remote Cardiac Monitoring
Others
Therapeutic and Surgical Devices
Ventricular Assist Devices (VAD)
Cardiac Rhythm Management (CRM) Devices
Catheter
Stents
Heart Valves
Others

By Application

Coronary Artery Disease (CAD)
Cardiac Arrhythmia
Heart Failure
Others

By End User

Hospitals
Specialty Clinics
Others

By Geography

North America (By Device Type, By Application, By End User, and By Country)
U.S. (By Application)
Canada (By Application)
Europe (By Device Type, By Application, By End User, and By Country/Sub-region)
U.K. (By Application)
Germany (By Application)
France (By Application)
Italy (By Application)
Spain (By Application)
Scandinavia (By Application)
Rest of Europe (By Application)
Asia Pacific (By Device Type, By Application, By End User, and By Country/Sub-region)
China (By Application)
India (By Application)
Japan (By Application)
Australia (By Application)
Southeast Asia (By Application)
Rest of Asia Pacific (By Application)
Latin America (By Device Type, By Application, By End User, and By Country/Sub-region)
Brazil (By Application)
Mexico (By Application)
Rest of Latin America (By Application)
The Middle East & Africa (By Device Type, By Application, By End User, and By Country/Sub-region)
GCC (By Application)
South Africa (By Application)
Rest of Middle East & Africa (By Application)

Please Note: It will take 5-6 business days to complete the report upon order confirmation.

1. Introduction: 1.1. Research Scope; 1.2. Market Segmentation; 1.3. Research Methodology; 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics: 3.1. Market Drivers; 3.2. Market Restraints; 3.3. Market Opportunities; 3.4. Market Trends
4. Key Insights: 4.1. Prevalence of Key Cardiovascular Diseases, By Key Countries, 2023; 4.2. Technological Advancements in Cardiovascular Devices; 4.3. New Product Launches, By Key Players; 4.4. Analysis of Key Cardiovascular Devices Deals; 4.5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.); 4.6. Pipeline Analysis, By Key Players; 4.7. Reimbursement Scenario, By Key Countries; 4.8. Analysis of Patient's Digital Health Adoption; 4.9. Impact of COVID-19 on the Market
5. Global Cardiovascular Devices Market Analysis, Insights and Forecast, 2019-2032: 5.1. Market Analysis, Insights and Forecast – By Device Type; 5.1.1. Diagnostic and Monitoring Devices; 5.1.1.1. Electrocardiogram (ECG); 5.1.1.2. Remote Cardiac Monitoring; 5.1.1.3. Others; 5.1.2. Therapeutic and Surgical Devices; 5.1.2.1. Ventricular Assist Devices (VAD); 5.1.2.2. Cardiac Rhythm Management (CRM) Devices; 5.1.2.3. Catheter; 5.1.2.4. Stents; 5.1.2.5. Heart Valves; 5.1.2.6. Others; 5.2. Market Analysis, Insights and Forecast – By Application; 5.2.1. Coronary Artery Disease (CAD); 5.2.2. Cardiac Arrhythmia; 5.2.3. Heart Failure; 5.2.4. Others; 5.3. Market Analysis, Insights and Forecast – By End User; 5.3.1. Hospitals; 5.3.2. Specialty Clinics; 5.3.3. Others; 5.4. Market Analysis, Insights and Forecast – By Region; 5.4.1. North America; 5.4.2. Europe; 5.4.3. Asia Pacific; 5.4.4. Latin America; 5.4.5. Middle East & Africa
6. North America Cardiovascular Devices Market Analysis, Insights and Forecast, 2019-2032: 6.1. Market Analysis, Insights and Forecast – By Device Type; 6.1.1. Diagnostic and Monitoring Devices; 6.1.1.1. Electrocardiogram (ECG); 6.1.1.2. Remote Cardiac Monitoring; 6.1.1.3. Others; 6.1.2. Therapeutic and Surgical Devices; 6.1.2.1. Ventricular Assist Devices (VAD); 6.1.2.2. Cardiac Rhythm Management (CRM) Devices; 6.1.2.3. Catheter; 6.1.2.4. Stents; 6.1.2.5. Heart Valves; 6.1.2.6. Others; 6.2. Market Analysis, Insights and Forecast – By Application; 6.2.1. Coronary Artery Disease (CAD); 6.2.2. Cardiac Arrhythmia; 6.2.3. Heart Failure; 6.2.4. Others; 6.3. Market Analysis, Insights and Forecast – By End User; 6.3.1. Hospitals; 6.3.2. Specialty Clinics; 6.3.3. Others; 6.4. Market Analysis, Insights and Forecast – By Country; 6.4.1. U.S.; 6.4.1.1. By Application; 6.4.2. Canada; 6.4.2.1. By Application
7. Europe Cardiovascular Devices Market Analysis, Insights and Forecast, 2019-2032: 7.1. Market Analysis, Insights and Forecast – By Device Type; 7.1.1. Diagnostic and Monitoring Devices; 7.1.1.1. Electrocardiogram (ECG); 7.1.1.2. Remote Cardiac Monitoring; 7.1.1.3. Others; 7.1.2. Therapeutic and Surgical Devices; 7.1.2.1. Ventricular Assist Devices (VAD); 7.1.2.2. Cardiac Rhythm Management (CRM) Devices; 7.1.2.3. Catheter; 7.1.2.4. Stents; 7.1.2.5. Heart Valves; 7.1.2.6. Others; 7.2. Market Analysis, Insights and Forecast – By Application; 7.2.1. Coronary Artery Disease (CAD); 7.2.2. Cardiac Arrhythmia; 7.2.3. Heart Failure; 7.2.4. Others; 7.3. Market Analysis, Insights and Forecast – By End User; 7.3.1. Hospitals; 7.3.2. Specialty Clinics; 7.3.3. Others; 7.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region; 7.4.1. U.K.; 7.4.1.1. By Application; 7.4.2. Germany; 7.4.2.1. By Application; 7.4.3. France; 7.4.3.1. By Application; 7.4.4. Spain; 7.4.4.1. By Application; 7.4.5. Italy; 7.4.5.1. By Application; 7.4.6. Scandinavia; 7.4.6.1. By Application; 7.4.7. Rest of Europe; 7.4.7.1. By Application
8. Asia Pacific Cardiovascular Devices Market Analysis, Insights and Forecast, 2019-2032: 8.1. Market Analysis, Insights and Forecast – By Device Type; 8.1.1. Diagnostic and Monitoring Devices; 8.1.1.1. Electrocardiogram (ECG); 8.1.1.2. Remote Cardiac Monitoring; 8.1.1.3. Others; 8.1.2. Therapeutic and Surgical Devices; 8.1.2.1. Ventricular Assist Devices (VAD); 8.1.2.2. Cardiac Rhythm Management (CRM) Devices; 8.1.2.3. Catheter; 8.1.2.4. Stents; 8.1.2.5. Heart Valves; 8.1.2.6. Others; 8.2. Market Analysis, Insights and Forecast – By Application; 8.2.1. Coronary Artery Disease (CAD); 8.2.2. Cardiac Arrhythmia; 8.2.3. Heart Failure; 8.2.4. Others; 8.3. Market Analysis, Insights and Forecast – By End User; 8.3.1. Hospitals; 8.3.2. Specialty Clinics; 8.3.3. Others; 8.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region; 8.4.1. Japan; 8.4.1.1. By Application; 8.4.2. China; 8.4.2.1. By Application; 8.4.3. India; 8.4.3.1. By Application; 8.4.4. Australia; 8.4.4.1. By Application; 8.4.5. Southeast Asia; 8.4.5.1. By Application; 8.4.6. Rest of Asia Pacific; 8.4.6.1. By Application
9. Latin America Cardiovascular Devices Market Analysis, Insights and Forecast, 2019-2032: 9.1. Market Analysis, Insights and Forecast – By Device Type; 9.1.1. Diagnostic and Monitoring Devices; 9.1.1.1. Electrocardiogram (ECG); 9.1.1.2. Remote Cardiac Monitoring; 9.1.1.3. Others; 9.1.2. Therapeutic and Surgical Devices; 9.1.2.1. Ventricular Assist Devices (VAD); 9.1.2.2. Cardiac Rhythm Management (CRM) Devices; 9.1.2.3. Catheter; 9.1.2.4. Stents; 9.1.2.5. Heart Valves; 9.1.2.6. Others; 9.2. Market Analysis, Insights and Forecast – By Application; 9.2.1. Coronary Artery Disease (CAD); 9.2.2. Cardiac Arrhythmia; 9.2.3. Heart Failure; 9.2.4. Others; 9.3. Market Analysis, Insights and Forecast – By End User; 9.3.1. Hospitals; 9.3.2. Specialty Clinics; 9.3.3. Others; 9.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region; 9.4.1. Brazil; 9.4.1.1. By Application; 9.4.1.1.1. Others; 9.4.2. Mexico; 9.4.2.1. By Application; 9.4.3. Rest of Latin America; 9.4.3.1. By Application
10. Middle East & Africa Cardiovascular Devices Market Analysis, Insights and Forecast, 2019-2032: 10.1. Market Analysis, Insights and Forecast – By Device Type; 10.1.1. Diagnostic and Monitoring Devices; 10.1.1.1. Electrocardiogram (ECG); 10.1.1.2. Remote Cardiac Monitoring; 10.1.1.3. Others; 10.1.2. Therapeutic and Surgical Devices; 10.1.2.1. Ventricular Assist Devices (VAD); 10.1.2.2. Cardiac Rhythm Management (CRM) Devices; 10.1.2.3. Catheter; 10.1.2.4. Stents; 10.1.2.5. Heart Valves; 10.1.2.6. Others; 10.2. Market Analysis, Insights and Forecast – By Application; 10.2.1. Coronary Artery Disease (CAD); 10.2.2. Cardiac Arrhythmia; 10.2.3. Heart Failure; 10.2.4. Others; 10.3. Market Analysis, Insights and Forecast – By End User; 10.3.1. Hospitals; 10.3.2. Specialty Clinics; 10.3.3. Others; 10.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region; 10.4.1. GCC Countries; 10.4.1.1. By Application; 10.4.2. South Africa; 10.4.2.1. By Application; 10.4.3. Rest of Middle East & Africa; 10.4.3.1. By Application
11. Competitive Analysis: 11.1. Global Market Share Analysis (2023); 11.2. Company Profiles; 11.2.1. Medtronic; 11.2.1.1. Overview; 11.2.1.2. Products & Services; 11.2.1.3. SWOT Analysis; 11.2.1.4. Recent Developments; 11.2.1.5. Strategies; 11.2.1.6. Financials (Based on Availability); 11.2.2. Boston Scientific Corporation; 11.2.2.1. Overview; 11.2.2.2. Products & Services; 11.2.2.3. SWOT Analysis; 11.2.2.4. Recent Developments; 11.2.2.5. Strategies; 11.2.2.6. Financials (Based on Availability); 11.2.3. Abbott; 11.2.3.1. Overview; 11.2.3.2. Products & Services; 11.2.3.3. SWOT Analysis; 11.2.3.4. Recent Developments; 11.2.3.5. Strategies; 11.2.3.6. Financials (Based on Availability); 11.2.4. Edwards Lifesciences Corporation; 11.2.4.1. Overview; 11.2.4.2. Products & Services; 11.2.4.3. SWOT Analysis; 11.2.4.4. Recent Developments; 11.2.4.5. Strategies; 11.2.4.6. Financials (Based on Availability); 11.2.5. Johnson & Johnson Services, Inc.; 11.2.5.1. Overview; 11.2.5.2. Products & Services; 11.2.5.3. SWOT Analysis; 11.2.5.4. Recent Developments; 11.2.5.5. Strategies; 11.2.5.6. Financials (Based on Availability); 11.2.6. GENERAL ELECTRIC COMPANY (GE Healthcare); 11.2.6.1. Overview; 11.2.6.2. Products & Services; 11.2.6.3. SWOT Analysis; 11.2.6.4. Recent Developments; 11.2.6.5. Strategies; 11.2.6.6. Financials (Based on Availability); 11.2.7. B. Braun Melsungen AG; 11.2.7.1. Overview; 11.2.7.2. Products & Services; 11.2.7.3. SWOT Analysis; 11.2.7.4. Recent Developments; 11.2.7.5. Strategies; 11.2.7.6. Financials (Based on Availability); 11.2.8. LivaNova PLC; 11.2.8.1. Overview; 11.2.8.2. Products & Services; 11.2.8.3. SWOT Analysis; 11.2.8.4. Recent Developments; 11.2.8.5. Strategies; 11.2.8.6. Financials (Based on Availability); 11.2.9. Siemens Healthcare GmbH; 11.2.9.1. Overview; 11.2.9.2. Products & Services; 11.2.9.3. SWOT Analysis; 11.2.9.4. Recent Developments; 11.2.9.5. Strategies; 11.2.9.6. Financials (Based on Availability); 11.2.10. LivaNova PLC; 11.2.10.1. Overview; 11.2.10.2. Products & Services; 11.2.10.3. SWOT Analysis; 11.2.10.4. Recent Developments; 11.2.10.5. Strategies; 11.2.10.6. Financials (Based on Availability); 11.2.11. Terumo Cardiovascular Systems Corporation; 11.2.11.1. Overview; 11.2.11.2. Products & Services; 11.2.11.3. SWOT Analysis; 11.2.11.4. Recent Developments; 11.2.11.5. Strategies; 11.2.11.6. Financials (Based on Availability); 12.